文献速递肝胆胰外科围术期管理与 ERAS

机器人与开放胰十二指肠切除术治疗远端胆管癌:多中心倾向评分匹配研究

Robotic versus open pancreaticoduodenectomy for distal cholangiocarcinoma: a multicenter propensity score-matched study.
PubMed 文献 · Surg Endosc · 2022-05-09

该多中心倾向评分匹配研究比较了机器人与开放胰十二指肠切除术治疗远端胆管癌的围手术期和肿瘤学结局。匹配后每组180例,两组在手术时间、淋巴结清扫、R0切除、重大并发症及长期生存方面无显著差异,但机器人组估计失血量更少、术后住院时间更短。

要点

  • 机器人与开放胰十二指肠切除术治疗远端胆管癌的可行性和安全性相当。
  • 机器人组估计失血量显著少于开放组(150.0 ml vs. 250.0 ml)。
  • 机器人组术后住院时间显著短于开放组(12.0天 vs. 15.0天)。

核心结论

  • 对于远端胆管癌,机器人胰十二指肠切除术的可行性和安全性与开放手术相当,肿瘤学和生存结局相似。

研究设计与样本

  • 多中心倾向评分匹配研究,纳入中国五中心2014年1月至2019年6月连续行机器人和开放胰十二指肠切除术的远端胆管癌患者。
  • 机器人组217例,开放组228例,经1:1倾向评分匹配后每组180例。

主要发现

  • 匹配前后两组在手术时间、淋巴结清扫数目、术中输血、血管切除、R0切除、术后重大并发症、再手术、90天死亡率和长期生存方面均无显著差异。
  • 机器人组估计失血量显著低于开放组(150.0 ml vs. 250.0 ml;P < 0.001)。
  • 机器人组术后住院时间显著短于开放组(12.0天 vs. 15.0天;P < 0.001)。
  • 多变量分析显示CA19-9、R0切除、N分期、神经周围侵犯和肿瘤分化与总生存和无复发生存显著相关。

临床怎么用

  • 在具备机器人手术条件的中心,机器人胰十二指肠切除术可作为远端胆管癌的可选术式,可能减少失血并缩短住院时间。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Pancreatoduodenectomy is the only potentially curative treatment for distal cholangiocarcinoma (DCC). In this study, we sought to compare the perioperative and oncological outcomes of robotic pancreaticoduodenectomy (RPD) and open pancreaticoduodenectomy (OPD) based on a multicenter propensity score-matched study. METHODS: Consecutive patients with DCC who underwent RPD or OPD from five centers in China between January 2014 and June 2019 were included. A 1:1 propensity score matching (PSM) was performed. Univariable and multivariable Cox regression analyses were used to identify independent prognosis factors for overall survival (OS) and recurrence-free survival (RFS) of these patients. RESULTS: A total of 217 patients and 228 patients underwent RPD and OPD, respectively. After PSM, 180 patients in each group were enrolled. There were no significant differences in operative time, lymph node harvest, intraoperative transfusion, vascular resection, R0 resection, postoperative major morbidity, reoperation, 90-day mortality, and long-term survival between the two groups before and after PSM. Whereas, compared with the OPD group, the RPD group had significantly lower estimated blood loss (150.0 ml vs. 250.0 ml; P < 0.001), and a shorter postoperative length of stay (LOS) (12.0 days vs. 15.0 days; P < 0.001). Multivariable analysis showed carbohydrate antigen 19-9 (CA19-9), R0 resection, N stage, perineural invasion, and tumor differentiation significantly associated with OS and RFS of these patients. CONCLUSIONS: RPD was comparable to OPD in feasibility and safety. For patients with DCC, RPD resulted in similar oncologic and survival outcomes as OPD.

来源:Surg Endosc,查看原文。版权归原作者所有。

引用

  1. Xu S, Zhang XP, Zhao GD, et al. Robotic versus open pancreaticoduodenectomy for distal cholangiocarcinoma: a multicenter propensity score-matched study. Surg Endosc. 2022. PMID: 35534733. doi:10.1007/s00464-022-09271-1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。